Homocysteine and cognitive function in institutionalised elderly A cross-sectional analysis

Eur J Nutr. 2006 Mar;45(2):70-8. doi: 10.1007/s00394-005-0566-7. Epub 2005 Aug 4.

Abstract

Background: Several cross-sectional, case-control and prospective studies revealed a relation between homocysteine and cognitive function or dementia. These studies included either patient populations or healthy, community- dwelling elderly people.

Aim of the study: In this study we tested the hypothesis that homocysteine was inversely associated with cognitive function in a population of institutionalised elderly (aged >/= 60 y; n = 157).

Methods: For testing this hypothesis baseline data of a recently conducted intervention study in institutionalised elderly (median age 83 years) were used. Cognitive function was evaluated by the cognitive subscale of the Alzheimer's disease Assessment Scale (ADAS-cog). The association between fasting plasma homocysteine level and cognitive function was investigated by multiple linear regression analysis.

Results: In the crude model homocysteine concentration was not significantly related to ADAS-cog score (beta = 0.061; p = 0.45). Age was found to be related to ADAS-cog score (beta = 0.161; p < 0.05). Adjusting for age did however not result in a relation between homocysteine and cognitive function.

Conclusions: In our study no association was found between homocysteine and cognitive function in a population of very old institutionalised subjects.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / blood
  • Alzheimer Disease / diagnosis
  • Biomarkers / blood
  • Cognition / drug effects
  • Cognition / physiology*
  • Cross-Sectional Studies
  • Female
  • Geriatric Assessment / methods*
  • Homes for the Aged
  • Homocysteine / blood*
  • Homocysteine / pharmacology
  • Humans
  • Linear Models
  • Male
  • Psychiatric Status Rating Scales*

Substances

  • Biomarkers
  • Homocysteine